Fei Wang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biotechnology top 1%
Papers in
-
- Microbial Metabolic Engineering and Bioproduction 45
- Enzyme Catalysis and Immobilization 39
- Plant biochemistry and biosynthesis 27
-
- Biofuel production and bioconversion 30
- Nanoplatforms for cancer theranostics 22
- Catalysis for Biomass Conversion 18
- Co-authors
- Xun Li (84 shared papers)Yu Zhang (59 shared papers)Yixin Dong (15 shared papers)Chaoqun You (24 shared papers)Like Ning (16 shared papers)Shaobing Peng (6 shared papers)Shenlin Huang (16 shared papers)Shun‐Yi Wang (10 shared papers)
- Journals
- ACS Sustainable Chemistry & Engineering (9 papers)Journal of Agricultural and Food Chemistry (9 papers)Organic Letters (9 papers)Industrial Crops and Products (8 papers)BioResources (8 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Fei Wang
278 papers receiving 6.7k citations
Fei Wang's Hit Papers
Peers
Comparison fields: 5 of 152
- Biomaterials 1.2k
- Biotechnology 502
- Biomedical Engineering 2.3k
- Biochemistry 233
- Organic Chemistry 1.1k
Countries citing papers authored by Fei Wang
This map shows the geographic impact of Fei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Wang more than expected).
Fields of papers citing papers by Fei Wang
This network shows the impact of papers produced by Fei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Wang. The network helps show where Fei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 291 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunogenic Cell Death Augmented by Manganese Zinc Sulfide Nanoparticles for Metastatic Melanoma Immunotherapy Hit paper breakdown → | 2022 | 174 |
| 2 | 2020 | 172 | |
| 3 | 2017 | 160 | |
| 4 | 2020 | 133 | |
| 5 | 2021 | 131 | |
| 6 | 2008 | 128 | |
| 7 | 2011 | 123 | |
| 8 | 2017 | 97 | |
| 9 | 2016 | 85 | |
| 10 | 2014 | 85 | |
| 11 | 2012 | 84 | |
| 12 | 2021 | 79 | |
| 13 | 2019 | 76 | |
| 14 | 2016 | 75 | |
| 15 | 2013 | 75 | |
| 16 | 2011 | 75 | |
| 17 | 2020 | 74 | |
| 18 | 2020 | 73 | |
| 19 | 2011 | 72 | |
| 20 | 2022 | 71 |
About Fei Wang
Fei Wang is a scholar working on Molecular Biology, Biomedical Engineering, Organic Chemistry, Biomaterials and Plant Science, having authored 291 papers that have together received 6.8k indexed citations. Recurring topics across this work include Microbial Metabolic Engineering and Bioproduction (45 papers), Enzyme Catalysis and Immobilization (39 papers), Nanoparticle-Based Drug Delivery (33 papers), Biofuel production and bioconversion (30 papers), Sulfur-Based Synthesis Techniques (28 papers), Plant biochemistry and biosynthesis (27 papers), Nanoplatforms for cancer theranostics (22 papers) and Catalysis for Biomass Conversion (18 papers). The work is most often cited by research in Biomaterials (1.2k citations), Biotechnology (502 citations), Biomedical Engineering (2.3k citations), Biochemistry (233 citations) and Organic Chemistry (1.1k citations). Fei Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xun Li, Yu Zhang, Yixin Dong, Chaoqun You, Like Ning, Shaobing Peng, Shenlin Huang, Shun‐Yi Wang, Hao Shi and Chanjuan Xi. Their work appears in journals such as ACS Sustainable Chemistry & Engineering, Journal of Agricultural and Food Chemistry, Organic Letters, Industrial Crops and Products and BioResources.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.